Publications by authors named "Mohammad Mahboubi-Rabbani"

Claim this Profile
I
Immunoinformatics-Based Multi-Epitope Vaccine Targeting Helicobacter Pylori.
Aytak Vahdat Khajeh Pasha, Mohammad Esfandiyari, Alireza Parnian, Mohammad Mahboubi-Rabbani, Maryam Bayanati

Cancer Rep (Hoboken)· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel dual inhibitor targeting FAAH and sEH: Design, synthesis, and in-vitro evaluation of oxadiazole analogues.
Maryam Salehi, Anna Sedaghat, Maryam Bayanati, Mohammad Ismail Mahboubi Rabbani, Elham Rezaee

Mol Divers· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances in Therapeutic Potential of Dual-Acting Aromatase/COX-2.
Ali Aliabadi, Mobina Tajdari, Sara Fakharinia, Niusha Sadat Ashrafizadeh, Maryam Bayanati, Mohammad Mahboubi-Rabbani

Anticancer Agents Med Chem· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023).
Mohammad Mahboubi-Rabbani, Amir Hossein Abdolghaffari, Mahsa Ghesmati, Ali Amini, Afshin Zarghi

Expert Opin Ther Pat· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chalcones as Potential Cyclooxygenase-2 Inhibitors: A Review.
Mohammad Mahboubi-Rabbani, Rosa Zarei, Mehdi Baradaran, Maryam Bayanati, Afshin Zarghi

Anticancer Agents Med Chem· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, Synthesis, Docking Studies, and Biological Evaluation of Novel 2-Hydroxyacetophenone Derivatives as Anti-HIV-1 Agents.
Samira Sooreni Oliaie, Mahdieh Safakish, Rouhollah Vahabpour Roudsari, Mohammad Mahboubi-Rabbani, Zahra Hajimahdi

Curr HIV Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Biological Evaluation of Novel Thiadiazole Derivatives as Antiplatelet Agents.
Mahsima Khakpash, Marjan Esfahanizadeh, Mohammad Mahboubi-Rabbani, Salimeh Amidi, Farzad Kobarfard

Iran J Pharm Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of dual NF-κB/IκB inhibitors using an integrative approaches.
Maryam Abbasi, Mohammad Mahboubi-Rabbani, Khosrow Kashfi, Hojjat Sadeghi-Aliabadi

J Biomol Struct Dyn· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer.
Ali Aliabadi, Elham Khanniri, Mohammad Mahboubi-Rabbani, Maryam Bayanati

Eur J Med Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural-Derived COX-2 Inhibitors as Anticancer Drugs: A Review of their Structural Diversity and Mechanism of Action.
Mohammad Mahboubi-Rabbani, Maryam Abbasi, Afshin Zarghi

Anticancer Agents Med Chem· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Benzo[4,5]imidazo[1,2-]pyrimidine derivatives as selective Cyclooxygenase-2 Inhibitors: Design, synthesis, docking studies, and biological evaluation.
Maryam Bayanati, Mona Khoramjouy, Mehrdad Faizi, Mahsa Azami Movahed, Mohammad Mahboubi-Rabbani

Med Chem Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel 2-(Diphenylmethylidene) Malonic Acid Derivatives as Anti-HIV Agents: Molecular Modeling, Synthesis and Biological Evaluation.
Mehrnaz Lotfaliei, Elham Rezaee, Zahra Hajimahdi, Mohammad Mahboubi Rabbani, Rezvan Zabihollahi

Iran J Pharm Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Human Carbonic Anhydrase/Cyclooxygenase-2 Inhibitors: A Promising Approach for Cancer Treatment.
Mohammad Mahboubi-Rabbani, Afshin Zarghi

Anticancer Agents Med Chem· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipoxygenase Inhibitors as Cancer Chemopreventives: Discovery, Recent Developments and Future Perspectives.
Mohammad Mahboubi-Rabbani, Afshin Zarghi

Curr Med Chem· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies.
Mohammad Mahboubi-Rabbani, Maryam Abbasi, Zahra Hajimahdi, Afshin Zarghi

Iran J Pharm Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase.
Iman Mahlooji, Maryam Shokri, Rana Manoochehri, Mohammad Mahboubi-Rabbani, Elham Rezaee

Arch Pharm (Weinheim)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3-mediated Apoptotic-enhancing Function of Sclareol Against Breast Cancer Cells and Cell Sensitization to Cyclophosphamide.
Havva Afshari, Mitra Nourbakhsh, Niloufar Salehi, Mohammad Mahboubi-Rabbani, Afshin Zarghi

Iran J Pharm Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis